The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients

Description

The objective of the study is to serve as a correlative study for patients enrolled on the RadCOMP trial (NCT02603341), a randomized phase III study of stage II and III breast cancer patients treated with either conventional photon radiation or proton beam radiation

Study Start Date

October, 26 2017

Estimated Completion Date

July 2027

Interventions

No interventions cited

Study ID

Massachusetts General Hospital -- 17-031

Status

Recruiting

Trial ID

NCT03270072

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

100

Sponsor

Massachusetts General Hospital

Inclusion Criteria

  • Eligible for and scheduled to receive radiation therapy on Radiation Therapy Oncology Group (RTOG) Trial 3510 (Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial). (NCT02603341)
  • Ability to understand and the willingness to sign a study-specific written informed consent document

Exclusion Criteria

  • There are no exclusion criteria.

Gender

All

Ages

21 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (4)

Study Location Distance Name Phone Email
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Rachel Jimenez MD 617-726-7559 RBJIMENEZ@Partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Rachel Jimenez MD 617-726-7559 RBJIMENEZ@Partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Rachel Jimenez MD 617-726-7559 RBJIMENEZ@Partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Rachel Jimenez MD 617-726-7559 RBJIMENEZ@Partners.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.